TY  - JOUR
AU  - Rodriguez-Hernandez, Maria A
AU  - Chapresto-Garzon, Raquel
AU  - Cadenas, Miryam
AU  - Navarro-Villaran, Elena
AU  - Negrete, Maria
AU  - Gomez-Bravo, Miguel A
AU  - Victor, Victor M
AU  - Padillo, Francisco J
AU  - Muntane, Jordi
PY  - 2020
DO  - 10.1038/s41419-020-2558-1
UR  - http://hdl.handle.net/10668/15529
T2  - Cell death & disease
AB  - Sorafenib and Regorafenib are the recommended first- and second-line therapies in patients with advanced hepatocellular carcinoma (HCC). Lenvatinib and Cabozantinib have shown non-inferior antitumoral activities compared with the corresponding...
LA  - en
PB  - Nature Publishing Group
KW  - Predictive markers
KW  - Liver cancer
KW  - Adult
KW  - Anilides
KW  - Apoptosis
KW  - Cell Culture Techniques
KW  - Cell Differentiation
KW  - Cell Proliferation
KW  - Cell Respiration
KW  - Female
KW  - Hep G2 Cells
KW  - Hepatocytes
KW  - Humans
KW  - Liver Neoplasms
KW  - Male
KW  - Mitochondria
KW  - Oxygen Consumption
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Quinolines
KW  - Sorafenib
KW  - Spheroids, Cellular
KW  - Tumor Suppressor Protein p53
TI  - Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells.
TY  - research article
VL  - 11
ER  -